Susan L Bellis Selected Research

Messenger RNA (mRNA)

1/2022	Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer.
4/2013	ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.
10/2008	ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan L Bellis Research Topics

Disease

23	Neoplasms (Cancer) 05/2024 - 06/2005
6	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 10/2008
4	Colonic Neoplasms (Colon Cancer) 04/2013 - 06/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2021
3	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2008
3	Wounds and Injuries (Trauma) 09/2017 - 09/2014
3	Carcinoma (Carcinomatosis) 04/2013 - 10/2008
2	Hypoxia (Hypoxemia) 10/2023 - 01/2018
2	Adenocarcinoma 01/2022 - 01/2018
2	Carcinogenesis 01/2018 - 01/2016
2	Osteosarcoma (Osteogenic Sarcoma) 12/2008 - 02/2004
1	Metaplasia 10/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 10/2020
1	Burns 09/2017
1	Ulcer 09/2017
1	Diabetic Foot 09/2017
1	Infections 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 12/2013
1	Thrombosis (Thrombus) 05/2011
1	Inflammation (Inflammations) 10/2008

Drug/Important Bio-Agent (IBA)

13	SialyltransferasesIBA 10/2023 - 07/2011
9	GlycosyltransferasesIBA 01/2021 - 06/2005
8	Sialic AcidsIBA 10/2023 - 10/2008
8	IntegrinsIBA 01/2022 - 02/2004
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
6	Glycoproteins (Glycoprotein)IBA 10/2023 - 10/2008
6	EnzymesIBA 01/2023 - 10/2008
5	Polysaccharides (Glycans)IBA 01/2023 - 10/2008
3	Gemcitabine FDA Link 05/2024 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2018 - 01/2017
3	salicylhydroxamic acid (SHAM)IBA 09/2017 - 09/2014
3	Small Interfering RNA (siRNA)IBA 12/2013 - 10/2008
2	Deferoxamine (Desferal)FDA LinkGeneric 10/2023 - 01/2018
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2022 - 06/2005
2	AntibodiesIBA 01/2022 - 04/2013
2	Death Domain ReceptorsIBA 01/2018 - 07/2011
2	CollagenIBA 09/2017 - 12/2008
2	Durapatite (Hydroxylapatite)IBA 12/2008 - 02/2004
2	Integrin beta1IBA 08/2008 - 06/2005
1	CholesterolIBA 05/2024
1	RNA (Ribonucleic Acid)IBA 05/2024
1	(+)-JQ1 compoundIBA 05/2024
1	sialosyl-Tn antigenIBA 01/2023
1	Lewis Blood Group AntigensIBA 01/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 01/2022
1	AntralIBA 10/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2018
1	PhosphotyrosineIBA 02/2018
1	Cell Surface ReceptorsIBA 02/2018
1	Gefitinib (Iressa)FDA Link 02/2018
1	oxalylglycineIBA 01/2018
1	JNK Mitogen-Activated Protein KinasesIBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2017
1	Hematoxylin (Haematoxylon)IBA 09/2017
1	Hyaluronic Acid (Hyaluronan)IBA 09/2017
1	Proteoglycans (Proteoglycan)IBA 09/2017
1	CytokinesIBA 09/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	VaccinesIBA 01/2016
1	silmitasertibIBA 12/2013
1	Casein Kinase II (Casein Kinase 2)IBA 12/2013
1	Caspase 3 (Caspase-3)IBA 04/2013
1	Cisplatin (Platino)FDA LinkGeneric 04/2013
1	PlatinumIBA 04/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2013
1	Glycoside Hydrolases (Endoglycosidases)IBA 12/2012
1	CaspasesIBA 07/2011
1	Phenobarbital (Luminal)FDA Link 05/2011
1	Biocompatible Materials (Biomaterials)IBA 12/2008
1	Fibronectins (Fibronectin)IBA 12/2008
1	Bovine Serum AlbuminIBA 12/2008
1	LectinsIBA 08/2008
1	LigandsIBA 08/2008
1	Galectin 3 (LGALS3)IBA 08/2008
1	adhesion receptorIBA 06/2005
1	Blocking AntibodiesIBA 02/2004

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2024 - 01/2022
2	Therapeutics 01/2023 - 02/2018
1	Drug Therapy (Chemotherapy) 01/2023
1	Chemoradiotherapy 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2011